| PDF (2MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-196414
- DOI to cite this document:
- 10.5283/epub.19641
Alternative links to fulltext:Pubmed
Abstract
Many physiological variables in hemato-oncology, e.g. the function of liver and kidney and hematopoiesis, show circadian changes. Consequently, the metabolism, elimination and myelotoxicity of cytostatic drugs are subjected to circadian variations in animal and man. Moreover, preliminary clinical data suggest that an optimal circadian timing may even increase the efficacy of anticancer ...

Owner only: item control page